Special Issue "Plant-Derived Medicines and Biological Activity Evaluation"
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: closed (28 February 2019)
Assist. Prof. Achinto Saha
Division of Pharmacology and Toxicology, College of Pharmacy, Dell Pediatric Research Institute, University of Texas at Austin, Austin, TX 78705, USA
Website | E-Mail
Interests: Prostate cancer, Cancer chemoprevention, Phytochemicals and their combinations for cancer chemoprevention. Obesity and dietary energy balance modulation on cancer, Chemokines and cytokines on cancer, Cancer microenvironment, Amino acid degrading engineered enzymes as novel therapeutic target for treatment of cancer
It is now well established that the intake of plant-based chemicals or phytochemicals is associated with numerous health benefits and can be used for the prevention or treatment of various life-threatening disease conditions including cancer, cardiovascular disease and diabetes. Recently, there has been an increase in interest in the use of plant-based chemicals, and the evidence suggests that in the last few decades numerous approved drugs have been based on the natural products. This has also encouraged many researchers to furthur investigate the biological activity of varoius plant-based chemicals, and also to elucidate the molecular mechanisms of actions of these effects, leading to the development of many novel lead compounds from plant-based chemicals or their semisynthetic derivatives.
This special issue of Medicines invites researchers to contribute original research articles as well as review articles related to the isolation, identification, biological activities and molecular mechanisms of action of plant-derived medicines (plant extracts, fractions, isolated pure compounds and their derivatives) that contribute to the knowledge in this area.
Prof. Dr. Achinto Saha
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 350 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- natural compounds
- alternative medicine